DRAM Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DRAM Antibodies for advanced research in cellular processes. DRAM Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DRAM, or Damage-Regulated Autophagy Modulator, plays a crucial role in the regulation of autophagy and cellular responses to stress. DRAM is involved in the modulation of cell death pathways and has significant implications in cancer biology and neurodegenerative diseases. Understanding DRAM function is essential for elucidating its role in maintaining cellular homeostasis and its potential as a therapeutic target. DRAM research continues to reveal new insights into autophagy regulation and stress response mechanisms. Investigating DRAM expression patterns helps researchers better understand disease progression and potential treatment strategies. Current studies focusing on DRAM are uncovering promising therapeutic applications in cancer research and neurological disorders. Santa Cruz Biotechnology monoclonal antibodies for DRAM research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.